Reply Re: "Comparison of preferences between onabotulinumtoxinA (Botox) and incobotulinumtoxinA (Xeomin) in the treatment of benign essential blepharospasm"

Ophthalmic Plast Reconstr Surg. 2014 Jan-Feb;30(1):77. doi: 10.1097/IOP.0000000000000092.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Blepharospasm / drug therapy*
  • Botulinum Toxins, Type A / therapeutic use*
  • Female
  • Humans
  • Male
  • Neuromuscular Agents / therapeutic use*
  • Oculomotor Muscles / drug effects*
  • Patient Preference / psychology*

Substances

  • Neuromuscular Agents
  • Botulinum Toxins, Type A